Anti-MAG First Administration to Human

NCT00622609 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebrovascular Accident

Interventions

DRUG: GSK249320A
DRUG: Placebo

Sponsor

GlaxoSmithKline